Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cyclo Therapeutics completes enrollment in phase 1 trial to evaluate Trappsol Cyclo for the treatment of Niemann-Pick Disease Type C
Cyclo Therapeutics completes enrollment in phase 1 trial to evaluate Trappsol Cyclo for the treatment of Niemann-Pick Disease Type C. Photo: courtesy of PublicDomainPictures from Pixabay.